HSP90B2P and osteoarthritis: As demonstrated in Supplementary Table 1, the regulatory effects of these treatments appear to be largely non-selective, suggesting that they may modulate not only HSP expression but also a broader range of molecular targets involved in osteoarthritis pathophysiology.